Abbott integrates CGM into Tandem's automated insulin pump
4.7 (249) · $ 25.99 · In stock
Abbott (NYSEABT) and Tandem Diabetes Care (Nasdaq:TNDM) announced the integration of FreeStyle Libre 2 CGM into the t:slim X2 insulin pump.
JPM24: With Abbott integration, Tandem finds 2nd CGM partner
Comparing Top Glucose Monitoring Devices
Medtronic's MiniMed 780G Insulin Pump Now Covered by Medicare
Shawn Noy on LinkedIn: #abbottproud
Adel Jahed posted on LinkedIn
Erica Scott - CSAM on LinkedIn: Vertex cuts ties to CRISPR Therapeutics' type 1 diabetes stem cell therapy
Virtual Diabetes Technology Meeting 2022 (english)
Shawn Noy on LinkedIn: #proudtobeabbott
Erica Scott - CSAM on LinkedIn: Abbott, Tandem launch new hybrid closed-loop insulin delivery system